Європейський Союз - шведська - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

Європейський Союз - шведська - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Європейський Союз - шведська - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - maintenance treatment of asthma in adults whose disease is not adequately controlled.

Швеція - шведська - Läkemedelsverket (Medical Products Agency)

karo healthcare ab - terbinafin - gel - 1 % - bensylalkohol hjälpämne; butylhydroxitoluen hjälpämne; etanol, vattenfri hjälpämne; terbinafin 10 mg aktiv substans - terbinafin

Швеція - шведська - Läkemedelsverket (Medical Products Agency)

aristo pharma gmbh - atorvastatinkalciumtrihydrat - filmdragerad tablett - 40 mg - atorvastatinkalciumtrihydrat 41,36 mg aktiv substans; laktosmonohydrat hjälpämne

Швеція - шведська - Läkemedelsverket (Medical Products Agency)

aristo pharma gmbh - atorvastatinkalciumtrihydrat - filmdragerad tablett - 30 mg - atorvastatinkalciumtrihydrat 31,02 mg aktiv substans; laktosmonohydrat hjälpämne